IPC provides clinicians with resources and training to best manage their psoriasis patients and conducts research into the disease to improve care worldwide.
Widespread pustules, fever, and a patient worsening by the hour. GPP, AGEP, or infection?
IPC’s free GPP Training covers the differential in five self-paced modules, plus severity scoring with the GPPGA and GPPASI.
https://t.co/29s6Z2Wyi1
#Psoriasis#GPP
Today we’re celebrating Nicora Gardner, our Director of Programs, on her 11th anniversary with IPC! Thank you for your leadership, care, and commitment over the past 11 years. We’re so grateful to have you on our team!
#IPCStaff#IPCCommunity
Psoriasis can look gray, purple, or hyper- or hypopigmented on darker skin, yet few dermatology resources show it. IPC’s Diverse Skin Images gallery is building that record with photos from members worldwide. Add yours: https://t.co/MKaBqoM6MQ
#Psoriasis#DiverseSkinImages
With great sadness, IPC shares that Dr. Craig Leonardi, an IPC founding member and former IPC president, passed away earlier this month. We extend our heartfelt condolences to his family and all who learned from and worked alongside him.
Read our tribute: https://t.co/wxiJYXy937
📢 New publication! 📚🎉
New research from GPA IPC 2024 GPA IPC Research Fellow Dr Bryan Guevara explores the impact of living with psoriasis among adults in the Philippines. 🇵🇭
📖https://t.co/QEptmetR76
👏 Congratulations to all involved!
#Psoriasis#Philippines@IpcPs
FDA labels for icotrokinra and risankizumab no longer require TB testing before treatment, aligning with the 2025 IPC and @NPF joint statement in JAAD. Both labels still advise against use in active TB.
https://t.co/iKPiJkOhke
#Psoriasis#Biologics
Female patients with psoriasis stop biologics sooner and report more adverse events. #IPCCouncilor Dr. Juul van den Reek and Dr. Liana Barenbrug share Dutch registry data and ask researchers to stratify every study by sex.
https://t.co/BjvY41jmCn
#Psoriasis#TakeTenWithIPC
Abstracts for @PsoriasisIFPA's 8th World Psoriasis & Psoriatic Arthritis Conference are due November 15, 23:59 CET.
Accepted abstracts may appear open access in a 𝘉𝘑𝘋 special issue.
Stockholm, Sweden, May 20–22, 2027
https://t.co/wC00r1igBy
#Psoriasis#PsoriaticArthritis
🔁 Could one maintenance injection a year keep psoriasis clear?
#IPCJrCouncilor Towhida Noor, MBBS, MD, reviews the pipeline: an oral TYK2 inhibitor that beat deucravacitinib head-to-head and antibodies dosed one to three times a year.
https://t.co/VzR14Epxk1
#Psoriasis
How do you treat psoriasis well in resource-rich and resource-limited settings? A new textbook edited by #IPCBoard Member and Treasurer Dr. Joel Gelfand brings together nearly 50 authors from 20 countries. All royalties support IPC.
Preorder: https://t.co/5VLe6vZLI1
#Psoriasis
What is life with psoriasis like in the Philippines? A new @PsoriasisAtlas survey from #IPCJrCouncilor Dr. Bryan Guevara, rooted in his IPC Fellowship, sets out to answer that.
https://t.co/1jazbjrC7I
#Psoriasis#IPCFellowship
🔁 Missed the psoriasis sessions at the 2026 EADV Congress in Vienna? IPC’s Congress Report covers the IPC Symposium: At Last! Personalized Medicine for Psoriasis, plus new therapy updates. Written by four #IPCJrCouncilors.
https://t.co/ubbbEUNV55
#EADV2026#Psoriasis
IPC welcomes four new #IPCCouncilor members: Dr. Tom Hillary (Belgium), Dr. Jiajing Lu (China), Dr. Nelson Mosha (Tanzania), and Professor Luis F. Santamaría-Babí (Spain).
Our network grows in Europe, Asia, and Africa.
https://t.co/hwxMeqUqWQ
#Psoriasis#Dermatology
Two sessions at the IPC Psoriasis Masterclass for North America belong to participants. Submit a hard case when you register (optional), and faculty will pick six to work through as a group.
Dallas, April 10–11, 2027
https://t.co/Zt8r0ru6iA
#Psoriasis#Dermatology
Is dose reduction of IL-17 and IL-23 inhibitors ready for practice?
In a new commentary, #IPCCouncilor Dr. José-Manuel Carrascosa weighs the BeNeBio trial and asks whether tapering fits a field focused on disease modification.
https://t.co/xGdMjJzwOv
#Psoriasis#Biologics
#Psoriasis & atopic dermatitis share more tissue biology than they appear to. Where does one end & the other begin? Select talks from the IEC-IPC Research Incubator at ESDR 2026 now available: https://t.co/4nvutQgE8z
Supported in part by Takeda & LEO Foundation.
@CouncilEczema
📰 The October edition of the IPC Psoriasis Review is here!
More than 12,000 dermatologists and health care professionals rely on IPC for updates on psoriasis research, education, and clinical care.
Read the October issue now: https://t.co/piIoTuyE9K
#PsoriasisNews#IPCNews
With great sadness, IPC shares that Dr. Craig Leonardi, an IPC founding member and former IPC president, passed away earlier this month. We extend our heartfelt condolences to his family and all who learned from and worked alongside him.
Read our tribute: https://t.co/wxiJYXy937
#WorldPsoriasisDay 2026 closes with young people. IPC Board Member Dr. Amy Paller on TNF inhibitor-induced eruptions in children with inflammatory bowel disease: the answer is usually to continue treatment. Watch: https://t.co/aVrSYPhXSL
#Psoriasis#LookBeyondMySkin
Today is #WorldPsoriasisDay. IPC Board Member and SPIN President Professor Tiago Torres on psoriatic arthritis: early diagnosis matters, because delayed treatment can lead to permanent joint damage. Look at the joints, too.
#PsoriaticArthritis#LookBeyondMySkin